Abstracts - faqs.org

Abstracts

News, opinion and commentary

Search abstracts:
Abstracts » News, opinion and commentary

U.S. Allows Continued Sale Of Abbott Weight-Loss Drug

Article Abstract:

The Food and Drug Administration ruled that Abbott Laboratories can continue to sell its weight-loss drug Meridia, but asked that the company remind doctors that people with cardiovascular problems should abstain from taking the drug.

Author: Saul, Stephanie
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2005
Government regulation (cont), Government regulation, Laws, regulations and rules, United States. Food and Drug Administration, ABT, Abbott Laboratories (Abbott Park, Illinois), Meridia (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


$60 Million Deal In Pfizer Suit

Article Abstract:

Pfizer Inc. has settled a class-action lawsuit over the life threatening side effects of the diabetes drug Rezulin. The drug has now been withdrawn from the market.

Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Class actions (Civil procedure), Compromise and settlement, Class action lawsuits, Settlements (Law), Brief Article, Drug therapy, Diabetes, Diabetes mellitus, Pfizer Inc., PFE, Rezulin (Medication)

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


New York's Pension Fund Files Own Suit Against Merck

Article Abstract:

New York's main pension fund has sued Merck and Co. for misleading shareholders about the safety of the discontinued pain medication Vioxx.

Author: Meier, Barry
Publisher: The New York Times Company
Publication Name: The New York Times
Subject: News, opinion and commentary
ISSN: 0362-4331
Year: 2004
Financial management, Pension, health, and welfare funds, Pension Funds & Benefit Plans, Pension Funds, New York, Investor relations, Merck & Company Inc.

User Contributions:

Comment about this article or add new information about this topic:

CAPTCHA


Subjects list: United States, Company legal issue, Cases, Product defects and recalls, Pharmaceutical industry, Complications and side effects
Similar abstracts:
  • Abstracts: U.S. Insurer Of Pensions Says Its Deficit Has Soared. U.S. Cancels Pension Plan At Kaiser. Pension Gap Is Closing, G.M. Reports
  • Abstracts: Eyetech Pins Its Hopes (And Shares) On New Drug. Medical Editors Likely To Call for Registration Of Drug Tests at Outset
  • Abstracts: Unmasking That Pension Consultant. U.S. Regulator Threatens Action Against A.I.G. On Press Releases. Funds Manager Is Said to Face S.E.C. Inquiry
  • Abstracts: Weakness in Demand Shrivels Japan's Output. Despite a Jolt, Japan's Mood Remains Upbeat. India Sets A Fast Pace, Expanding 8.2% in Year
  • Abstracts: Witness Says Ebbers Urged Manipulations At WorldCom. Bernard Ebbers: Victim Himself Or Mastermind? S.E.C. Wants to Know How Telecoms Count Customers
This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.
Some parts © 2025 Advameg, Inc.